Mycobacteria Diagnostics
Slow growing Mycobacterium species directly identified by 16S-23S rDNA ISR analysis
Published in Tuberculosis Week, April 10th, 2006
According to recently published research from Australia, "To obtain Mycobacterium species identification directly from clinical specimens and cultures, the 16S-23S rDNA spacer (ISR) was amplified using previously published primers.
"The restriction enzyme that could potentially produce the most restriction fragment length polymorphisms (RFLPs) was determined from all available ISR DNA sequences in GenBank to produce a novel data set of RFLPs for 31 slowly growing Mycobacterium species."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Tuberculosis Week
Source: Tuberculosis Week (2006-04-10)
More Articles from Tuberculosis Week
- Tuberculosis Diagnosis
ELISPOT and skin test cut-offs determined for MTB diagnosis in Gambia - Tuberculosis Drug Resistance
Multidrug-resistant tuberculosis and rifampin resistance prevalence high in Bujumbura - Tuberculosis Drug Resistance
Multidrug-resistant tuberculosis risk factors in Europe determined - Tuberculosis Therapy
Fluoroquinolones active against drug-resistant tuberculosis - Diagnostics
Medical Services to deliver Dengue Fever rapid test kits to Middle East - Genetics & Genomics
Reports describe recent advances in genetics & genomics research - More from this issue of Tuberculosis Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
